A Decision Score provides prognostic discrimination for 10-year locoregional recurrence, with rising score associated with higher recurrence risk after breast-conserving surgery. A Radiation ...

Over a median follow-up in responders of 18.0 months (range 15-21), the median duration of complete response was 18.0 months ...

Working with your healthcare team to plan next steps ...

An ipsilateral breast cancer recurrence after long disease-free interval may still permit curative-intent local therapy, with ...

Women who previously had endometrial cancer and used vaginal estrogen therapy did not have higher risk for cancer recurrence than those who did not use vaginal hormone therapy, according to findings ...

The gut microbiome at time of surgery may significantly impact recurrence of colorectal cancer.An analysis of nearly 300 ...

One large study found that more advanced cases of colorectal cancer had a higher likelihood of returning. For example, if participants had stage 3 colon cancer, almost 25 percent experienced a ...

Researchers at NYU Langone Health and its Perlmutter Cancer Center have revealed that blood tests could predict the return of skin cancer. Melanoma is a less common form of skin cancer that is more ...

National survey of more than 1,100 bladder cancer patients finds nearly 80% report fear of recurrence, rising above 90% among patients under 50Many respondents report undergoing five or more ...

Worries have persisted that cancer survivors in remission might face increased recurrence risk when treated with biologic drugs for autoimmune disease. This Danish study of rheumatoid arthritis ...

Recent advances in healthcare research have increasingly leveraged routinely collected administrative data to monitor cancer recurrence. This approach circumvents the delays and resource-intensive ...

Despite the increased incidence of endometrial cancer in younger women, there is limited research regarding the safety of local, low-dose vaginal estrogen therapy (ET) for survivors. A new study ...